They're often cheaper and easier to get than Ozempic, but doctors say compounded GLP-1 drugs come with serious risks.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Compounded GLP-1 drugs creating concern among doctors and FDA | 0 | 6.75 | 27-07-2026 |
| 2 | The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients | 0 | 13.02 | 24-07-2026 |
| 3 | Nationwide recall on these compound GLP-1 drugs | 0 | 23.33 | 23-10-2026 |
| 4 | Nationwide recall on these compound GLP-1 drugs | 0 | 23.33 | 23-10-2026 |
| 5 | Nationwide recall on these compound GLP-1 drugs | 0 | 23.33 | 24-10-2026 |
| 6 | Nationwide recall on these compound GLP-1 drugs | 0 | 23.33 | 24-10-2026 |
| 7 | Nationwide recall on these compound GLP-1 drugs | 0 | 23.33 | 23-10-2026 |
| 8 | Nationwide recall on these compound GLP-1 drugs | 0 | 23.33 | 23-10-2026 |
| 9 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |
| 10 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |